4.7 Article

Is Huntington's disease a tauopathy?

Journal

BRAIN
Volume 139, Issue -, Pages 1014-1025

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/brain/aww021

Keywords

tau; Huntington's disease

Funding

  1. Biomedical Doctoral Awards from the Alzheimer Society of Canada
  2. Canadian Institute of Health Research [MOP-106423, PCN-102993]
  3. Fonds de Recherche du Quebec en Sante [16205, 20048, 28941]
  4. Natural Sciences and Engineering Research Council of Canada [354722]
  5. Canadian Institutes of Health Research [MOP-136893]
  6. Huntington's Disease Society of America Inc.

Ask authors/readers for more resources

Recent reports have suggested that Huntington's disease may be a tauopathy. Gratuze et al. review the evidence, including the mechanisms by which mutant huntingtin may induce tau pathology, and the possibility that tau contributes to the observed cognitive/motor impairments. They conclude by proposing that Huntington's disease is a secondary tauopathy.Recent reports have suggested that Huntington's disease may be a tauopathy. Gratuze et al. review the evidence, including the mechanisms by which mutant huntingtin may induce tau pathology, and the possibility that tau contributes to the observed cognitive/motor impairments. They conclude by proposing that Huntington's disease is a secondary tauopathy.Tauopathies are a subclass of neurodegenerative diseases typified by the deposition of abnormal microtubule-associated tau protein within the cerebral tissue. Alzheimer's disease, progressive supranuclear palsy, chronic traumatic encephalopathy and some fronto-temporal dementias are examples of the extended family of tauopathies. In the last decades, intermittent reports of cerebral tau pathology in individuals afflicted with Huntington's disease-an autosomal dominant neurodegenerative disorder that manifests by severe motor, cognitive and psychiatric problems in adulthood-have also begun to surface. These observations remained anecdotal until recently when a series of publications brought forward compelling evidence that this monogenic disorder may, too, be a tauopathy. Collectively, these studies reported that: (i) patients with Huntington's disease present aggregated tau inclusions within various structures of the brain; (ii) tau haplotype influences the cognitive function of Huntington's disease patients; and (iii) that the genetic product of the disease, the mutant huntingtin protein, could alter tau splicing, phosphorylation, oligomerization and subcellular localization. Here, we review the past and current evidence in favour of the postulate that Huntington's disease is a new member of the family of tauopathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available